Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement ...
BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic ...
Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results and ...
Completed Successful FDA End-of-Phase 2 Meeting Following Positive Nebokitug Phase 2 SPRING Trial Resultsin Primary Sclerosing Cholangitis ...